drugset / Trial / NCT06164392

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

NCT06164392 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography

Timeline

Start
2024-12-28
Primary completion
2024-12-28
Completion
2024-12-28

Outcome

Outcome not reported

Stopped (Enrollment): “The attendings who were to participate did not want to alter their standard neuroma treatment of neurotomy and TMR, as opposed to dissecting the end of all neuromas before neurotomy. No patients were enrolled in the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent — Intravenous

Indications